Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids

Published:2022-02-28 Issue:2 Volume:5 Page:e220548
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Albuquerque Arthur M.¹,Tramujas Lucas²,Sewanan Lorenzo R.³,Williams Donald R.⁴,Brophy James M.⁵

Affiliation:

1. School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

2. HCor Research Institute, Sao Paulo, Brazil

3. Department of Internal Medicine, Columbia University, New York, New York

4. Department of Psychology, University of California, Davis

5. McGill Health University Center, Montreal, Québec, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789444/albuquerque_2022_oi_220037_1647360024.20624.pdf

Reference37 articles.

1. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis.;Shankar-Hari;JAMA,2021

2. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.;Wijeysundera;J Clin Epidemiol,2009

3. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc bayesian analysis of a randomized clinical trial.;Goligher;JAMA,2018

4. Bayesian interpretation of the EXCEL trial and other randomized clinical trials of left main coronary artery revascularization.;Brophy;JAMA Intern Med,2020

5. Invited commentary: the need for cognitive science in methodology.;Greenland;Am J Epidemiol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19;Journal of Infection;2024-10

2. A comparison of computational algorithms for the Bayesian analysis of clinical trials;Clinical Trials;2024-05-16

3. Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review;2024-05-06

4. Treatment with inhaled aerosolised ethanol reduces viral load and potentiates macrophage responses in an established influenza mouse model;Experimental Lung Research;2024-04-29

5. A Bayesian Reanalysis of the Overall and Sex-Disaggregated Results of the Neonatal Oxygenation Prospective Meta-Analysis (NeOProM);Antioxidants;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3